Mendus AB (IMMU) NPV

Sell:4.85 SEKBuy:5.12 SEKPrice increased0.24 SEK (4.91%)

Prices delayed by at least 15 minutes
Sell:4.85 SEK
Buy:5.12 SEK
Change:Price increased0.24 SEK (4.91%)
Deal now
Prices delayed by at least 15 minutes
Sell:4.85 SEK
Buy:5.12 SEK
Change:Price increased0.24 SEK (4.91%)
Prices delayed by at least 15 minutes
Deal now

Key metrics

Open4.89 SEK
Previous close4.89 SEK
Market capSEK 306.04m
P/E ratio-
Volume13,774
Dividend yield0.00%
EMS-

Company information

Mendus AB (publ), formerly Immunicum AB, is a Sweden-based company that is engaged in the biopharmaceutical sector. The Company develops immunotherapy for therapeutic treatment of cancer and infectious diseases. The ...

  • LocationSweden
  • SectorHealthcare
  • IndustryBiotechnology & Drugs
  • CurrencySEK
  • Shares in issue62.58m
Dates and announcementsDirector deals

Earnings and financials

Take a closer look at this company’s financial statements and dividend information.

Dividends

  • Dividend per share -
  • Ex-dividend date -
  • Payment date -

Balance sheet 2025

Total assetsSEK 628.32m
Total liabilitiesSEK 43.26m
Net debt-SEK 45.81m

Costs and Charges

Find out how much you might pay in costs and charges if you choose this investment.

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete and accepts no responsibility for how it may be used. TradingView Lightweight Charts™ Copyright (c) 2026 TradingView, Inc. https://www.tradingview.com/.